Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Robbins

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.
Science (New York, N.Y.)|December 11, 2020
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancerSri Krishna, Frank J Lowery, Amy R Copeland, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitisMaria R Parkhurst, James C Yang, Russell C Langan, et al.
Journal for Immunotherapy of Cancer|May 30, 2024
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypesNoam Levin, Sanghyun P Kim, Charles A Marquardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Nature Medicine|July 11, 2024
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim resultsMaria Parkhurst, Stephanie L Goff, Frank J Lowery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic MelanomaShoshana T Levi, Amy R Copeland, Shirley Nah, et al.
Cancer Cell|December 1, 2023
Phenotypic signatures of circulating neoantigen-reactive CD8<sup>+</sup> T cells in patients with metastatic cancersRami Yossef, Sri Krishna, Sivasish Sindiri, et al.
Oncoimmunology|July 4, 2012
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patientsPia Kvistborg, Chengyi Jenny Shu, Bianca Heemskerk, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Rapid enrichment of progenitor exhausted neoantigen-specific CD8 T cells from peripheral bloodMamduh Khateb, Raina Jung, Stav Leibou, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.
Science (New York, N.Y.)|December 11, 2020
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancerSri Krishna, Frank J Lowery, Amy R Copeland, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2010
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitisMaria R Parkhurst, James C Yang, Russell C Langan, et al.
Journal for Immunotherapy of Cancer|May 30, 2024
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypesNoam Levin, Sanghyun P Kim, Charles A Marquardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Nature Medicine|July 11, 2024
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim resultsMaria Parkhurst, Stephanie L Goff, Frank J Lowery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic MelanomaShoshana T Levi, Amy R Copeland, Shirley Nah, et al.
Cancer Cell|December 1, 2023
Phenotypic signatures of circulating neoantigen-reactive CD8<sup>+</sup> T cells in patients with metastatic cancersRami Yossef, Sri Krishna, Sivasish Sindiri, et al.
Oncoimmunology|July 4, 2012
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patientsPia Kvistborg, Chengyi Jenny Shu, Bianca Heemskerk, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Rapid enrichment of progenitor exhausted neoantigen-specific CD8 T cells from peripheral bloodMamduh Khateb, Raina Jung, Stav Leibou, et al.
Pageof 26